Tandem Diabetes Care (TNDM)

$44.00 0.00 (0.00%)

16:00 EDT TNDM Stock Quote Delayed 30 Minutes

TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

TNDM stock results show that Tandem Diabetes Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Shhh! 7 Small-Cap Stocks That Can Double by 2025

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

Volume:

Previous Close -

Market Cap 2.77B

PE Ratio -20.28

EPS -2.17

Volume (Avg. Vol.) 2

Day's Range -

52-Week Range $13.82 - $47.00

Dividend & Yield N/A (N/A)

TNDM Stock Predictions, Articles, and Tandem Diabetes Care News

From InvestorPlace
From the Web

7 Battered Stocks That Could TRIPLE by 2024

By Josh Enomoto, InvestorPlace Contributor Jul 3, 2023

While heavily deflated enterprises are usually that way for a reason, speculators may gamble on these battered stocks to buy.

7 Names to Buy as Stock Market Crash Fears Fester

By Josh Enomoto, InvestorPlace Contributor Jun 5, 2023

With a downturn representing a non-zero probability, investors should start thinking about these stocks to buy before crash.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Nov 3, 2022

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

5 Top Stock Trades for Friday: SIG, MSFT, TNDM

By Bret Kenwell, InvestorPlace Contributor Jan 16, 2020

Signet Jewelers, Microsoft, Tandem Diabetes, InMode and Taiwan Semiconductor were our top stock trades for Friday -- and here's why.

8 Stocks to Buy That Are Growing Faster Than Amazon

By James Brumley, InvestorPlace Feature Writer Jul 19, 2019

Neurocrine Biosciences, Facebook and Etsy are just some of the stocks to buy if you want growth because they're outpacing Amazon.

10 Cheap Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor May 2, 2019

The idea to "sell in May and go away" is as tired as its usage. Now is the time to go contrarian and buy stocks on the cheap.

Why Tandem Diabetes Stock Will Rally Much Further

By Chris Lau, InvestorPlace Contributor Apr 5, 2019

Tandem reported solid Q4 numbers, and TNDM stock has multiple, other potential positive catalysts.

5 Top Stock Trades for Tuesday: BAC, NFLX, ATVI, INTC

By Bret Kenwell, InvestorPlace Contributor Apr 1, 2019

Tandem Diabetes, Netflix, Activision Blizzard, Intel and Bank of America are our top stock trades to watch going into Tuesday.

Wait for the Inevitable Pullback to Buy TNDM Stock

By Will Healy, InvestorPlace Contributor Feb 28, 2019

TNDM stock should enjoy a bright, long-term future, but the quick run-up could mean Tandem Diabetes Care stock sees a near-term pullback.

5 Healthcare Stocks to Buy for Complete Portfolio Wellness

By Josh Enomoto, InvestorPlace Contributor Oct 10, 2018

Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight.

Tandem Diabetes Is Firing on All Cylinders

By Chris Lau, InvestorPlace Contributor Sep 11, 2018

Tandem Diabetes sold shares of TNDM stock, but Tandem Diabetes stock continued to rocket higher. TNDM's Q2 results impressed investors, but its seasonally strong Q4 earnings could wow them more.

Why Tandem Stock Could Continue Its Rally

By Chris Lau, InvestorPlace Contributor Jun 25, 2018

Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside.

Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet

By Chris Lau, InvestorPlace Contributor Apr 13, 2018

Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock.

4 Top Growth Picks as MedTech Battle Rages On

By Oct 16, 2017

Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

Why Tandem Diabetes Stock Just Jumped 22%

From The Motley Fool May 3, 2024

Tandem Diabetes stock is showing great growth -- but miserable profits.

1 Beaten-Down Stock That Could Make You Richer

From The Motley Fool Apr 7, 2024

Don't give up on this healthcare stock too soon.

Why Tandem Diabetes Care Stock Was Zooming Higher Today

From The Motley Fool Mar 26, 2024

One product in particular could juice the company's fundamentals, a pundit believes.

Tandem Diabetes (NASDAQ:TNDM): Investors Look to Innovation to Drive the Stock Higher

From TipRanks Feb 28, 2024

Tandem Diabetes Care (NASDAQ:TNDM) designs and markets state-of-the-art insulin pumps and infusion sets. Despite its recent lackluster Q4 results, market sentiment ...

Why Tandem Diabetes Care Stock Popped Today

From The Motley Fool Feb 22, 2024

Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.

2 Beaten-Down Stocks That Are Worth Buying

From The Motley Fool Feb 4, 2024

Don't be too quick to ignore these stocks.

Tandem Diabetes Care (TNDM)

TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024

Shhh! 7 Small-Cap Stocks That Can Double by 2025

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Tandem Diabetes Care (TNDM)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TNDM Stock Predictions, Articles, and Tandem Diabetes Care News

Subscriber Sign in